DEA Schedule CIV
Strength
15 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107010501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204318On Market Since
3/20/2017
Pharmacological Classes
Related Drugs
Same classification
NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203003•Taro Pharmaceuticals U.S.A. Inc.
$0.0678
per ML
PHENTERMINE 37.5 MG TABLET
Generic
11534016001•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016003•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016030•Sunrise Pharmaceutical Inc.
$0.0694
per EA
GS SINUS NASAL SPRAY 0.05%
Generic
00113081710•L. Perrigo Company
$0.0737
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
00904676130•Major Pharmaceuticals
$0.0737
per ML
GS NASAL SPRAY 0.05%
Generic
00113030410•L. Perrigo Company
$0.0778
per ML